Herceptin Trastuzumab Injection (600mg) is a targeted therapy used primarily for the treatment of certain types of breast cancer and gastric cancer that overexpress the HER2 protein. The active ingredient, Trastuzumab, is a monoclonal antibody that specifically binds to the HER2 receptor, inhibiting the growth of cancer cells that rely on this protein for proliferation. This injection is typically administered intravenously and is often part of a comprehensive treatment plan that may include chemotherapy or other therapies. The formulation of Herceptin includes Trastuzumab as the active component, along with various excipients to ensure stability and efficacy. By targeting the HER2 receptor, Herceptin plays a crucial role in improving patient outcomes and is a cornerstone in the management of HER2-positive cancers.